Briggs FBS, Hill E, Abboud H., et al. - Stratifying by age, gender, and race, researchers assessed the prevalence of hypertension (HTN) in multiple sclerosis (MS)(n = 122,660) and non‐MS (n = 37,075,350) cohorts in this cross‐sectional analysis. They utilized 37 million unique electronic health records available in the IBM Explorys Enterprise Peformance Management: Explore database (Explorys) spanning the US, making this is the largest inquiry of its kind to date. Regardless of sex and race, MS patients had a significantly higher incidence of HTN vs the non‐MS population. A progressive rise in HTN prevalence with age was noted in both cohorts, as was a higher prevalence in black Americans and in males. Since These findings highlight the necessity for aggressive screening for, as well as management of, HTN in MS patients, as HTN represents the leading global risk factor for disability and mortality.